Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Eiji Nakano
Institution:
National Cancer Centre Japan
Observed institution:
National Cancer Centre Japan
OpenAlex ID:
A5158043648
Pembrolizumab plus lenvatinib in the treatment of unresectable cutaneous angiosarcoma: a study protocol of multicentre, open-label phase II study (NCCH2213, PLAS)
2026
·
Dai Ogata
, Eiji Nakano
, et al.
·
BMJ Open
PDF
Show more works
View as search
Works count:
1
Citation count:
H-index:
I10-index:
Year
Topic
Type
